SCHEMBL6095070

SCHEMBL6095070

ClCc1nc2ccccc2n1Cc1nc2ccccc2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
HTT P42858 1/20 0.49
LMNA P02545 1/20 0.48
HPGD P15428 1/20 0.47
DDAH1 O94760 1/20 0.46
POLB P06746 1/20 0.46
EGLN3 Q9H6Z9 1/20 0.46
DRD4 P21917 5/20 0.45
DRD2 P14416 1/20 0.45
GAA P10253 1/20 0.44
RAB9A P51151 2/20 0.43
BCHE P06276 1/20 0.43
NPC1 O15118 1/20 0.43
PON1 P27169 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6881772 0.82 DRD4 (0.48) HTTLMNAHPGDDDAH1POLB
SCHEMBL7746431 0.78 HTT (0.55) MEN1KMT2AHTTHPGDDDAH1
SCHEMBL103530 0.77 MEN1 (1.00) MEN1KMT2AHTTLMNARAB9A
SCHEMBL6095517 0.76 KCNH2 (0.48) MEN1KMT2AHTTLMNAHPGD
SCHEMBL6093816 0.76 KCNH2 (0.48) MEN1KMT2AHTTLMNAHPGD
SCHEMBL21784389 0.76 ALDH1A1 (0.41) MEN1KMT2AHTTLMNAHPGD
Hydrochloric Acid SCHEMBL10353601 0.76 MEN1 (0.97) MEN1KMT2AHTTLMNARAB9A
SCHEMBL119941 0.75 DDAH1 (0.66) DDAH1POLBGAARAB9ABCHE
SCHEMBL6092572 0.75 HTT (0.49) MEN1KMT2AHTTLMNADRD4
SCHEMBL6095609 0.75 HTT (0.49) MEN1KMT2AHTTHPGDDRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142365-A1 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2006-06-29 US disclosed
US-7030150-B2 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2006-04-18 US disclosed
US-20030119754-A1 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2003-06-26 US disclosed
WO-2002092575-A1 BENZIMIDAZOLE COMPOUNDS AND ANTIVIRAL USES THEREOF TRIMERIS, INC. (US) 2002-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142365-A1 Benzimidazole compounds and antiviral uses thereof MAVS, ZC3HAV1, TIMM13 MEN1 4444/4885KMT2A 1041/4885HTT 3180/4885
US-20030119754-A1 Benzimidazole compounds and antiviral uses thereof MAVS, ZC3HAV1, TIMM13 MEN1 4444/4885KMT2A 1041/4885HTT 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.